Our PAX7 target gene repression biomarker18 discriminates control, non-inflamed and inflamed FSHD muscle, while the discriminatory power of DUX4 target gene signatures is limited to distinguishing control from FSHD muscle (Table 2). The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.